Synterium Genomics

The project Synterium Genomics is aimed at finding solutions in the field of diagnosis, treatment, and prevention of diseases that would be optimal for the chosen person taking into account their peculiarities.

The project Synterium Genomics is aimed at finding solutions in the field of diagnosis, treatment, and prevention of diseases that would be optimal for the chosen person taking into account their peculiarities.

AIMS OF THE PROJECT

The central research of the Synterium Genomics project is aimed at analyzing the human genome. The results of genomic studies are applicable for personal identification of genetic predispositions to diseases, the efficacy of diagnostics and treatment, use of cosmetics, selection of proper nutrition and physical activities.

As part of the project objectives, it is planned to create a digital repository of DNA samples, GSG Computing Storage, and a physical repository of biological materials, Biobank, for database accumulation. Digital data storage, processing, and analysis of information is provided by the technological and computational capabilities of the GSG GectaHPC Blockchain within Synterium Finance Project.

Stages of project development

GSG Storage
Q3 2018 – Q2 2019

The launch of GSG Computing Storage, a digital DNA sample repository that allows research centers to conduct full-scale genome studies at a higher technology level at minimal cost. Research organizations have remote access to a dedicated virtual repository to store their database of digital genome samples, to process and analyze them.

Building BioBank
Q3 2018 - Q2 2020

The construction of a physical Biobank for the extraction and storage of biological liquids, tissues, DNA, RNA, as well as the preservation of related information.

GSG Research
Q3 2019 – Q2 2020

Providing unrestricted access to research organizations to the entire accumulated DNA sample base stored in GSG Computing Storage for research purposes.

Conducting its own genomic research in partnership with commercial and scientific centers.

BioBank Launch
Q2 2020 – Q1 2021

The commercial launch of corporate services – access of research centers to stored information and processing of biological materials.

Start of sales of individual services – carrying out genetic tests and storage of test results data, as well as related services.

Organization of storage of bio-materials for printing and storage of printed bio-copies.

GSG Investments
Q2 2020 – Q1 2021

The creation of a financial structure for the development of the program of Bioprint Technology for restoration of human organs and tissues with the help of bioengineering.

GSG Integration
Q2 2021 – Q2 2022

Improved computing capabilities of GSG Computing Storage and its integration with third-party systems.

Biobank 3D BioPrinting
Q2 2021 – Q2 2022

The interaction with scientific organizations on development and improvement of 3D printing technology of biological constructions.